Last reviewed · How we verify
NCT05734534
Effects of BFR Interventions in Healthy Individuals and Individuals With COPD
NA trial testing BFR during training in Healthy in 105 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Morten Hostrup, PhD |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 105 |
| Start date | 1 March 2023 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- BFR during training
- BFR during rest
Conditions studied
Sponsor
Morten Hostrup, PhD — full company profile →
Who can join
18 and older, any sex, with Healthy or COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to investigate the effect of different blood flow restriction (BFR) interventions on muscle function and adaptations both in healthy well-trained individuals and individuals diagnosed with COPD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05734534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Morten Hostrup, PhD trials
Trials by the same sponsor.
- NCT07421024 — Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle · Phase 2 · not yet recruiting
- NCT06188767 — Testosterone-induced Muscle Memory and Underlying Mechanisms · NA · recruiting
- NCT06067100 — U-LABA/ICS Effects on Exercise Performance, Indacaterol · NA · recruiting
- NCT06105671 — U-LABA/ICS Effects on Exercise Performance, Formoterol · NA · completed
- NCT06077019 — Role of Lung Function for Exercise Capacity in Well-trained Individuals · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05734534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Morten Hostrup, PhD
- Last refreshed: 21 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05734534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing